Page last updated: 2024-12-05

gliotoxin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Gliotoxin: A fungal toxin produced by various species of Trichoderma, Gladiocladium fimbriatum, Aspergillus fumigatus, and Penicillium. It is used as an immunosuppressive agent. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

gliotoxin : A pyrazinoindole with a disulfide bridge spanning a dioxo-substituted pyrazine ring; mycotoxin produced by several species of fungi. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID6223
CHEMBL ID331627
CHEBI ID5385
SCHEMBL ID54420
MeSH IDM0009277

Synonyms (54)

Synonym
6-hydroxy-3-(hydroxymethyl)-2-methyl-2,3,6,10-tetrahydro-5ah-3,10a-epidithiopyrazino[1,2-a]indole-1,4-dione
ccris 4025
brn 0050675
10h-3,10a-epidithiopyrazino(1,2-a)indole-1,4-dione, 2,3,5a,6-hydroxy-3- (hydroxymethyl)-2-methyl-, (3r-(3-alpha,5a-beta,6-beta,10a-alpha))-
c13h14n2o4s2
ai3-62383
s.n. 12870
10h-3,10a-epidithiopyrazino(1,2-a)indole-1,4-dione, 2,3,5a,6-tetrahydro-6-hydroxy-3-(hydroxymethyl)-2-methyl-
QTL1_000040
BSPBIO_001237
nsc 102866
nsc102866 ,
67-99-2
aspergillin
nsc-102866
gliotoxin
gliotoxin from gliocladium fimbriatum
NCGC00163466-01
NCGC00163466-02
HMS1990M19
bdbm50134315
7-hydroxy-11-hydroxymethyl-12-methyl-14,15-dithia-9,12-diazatetracyclo[9.2.2.01,9.03,8]pentadeca-3,5-diene-10,13-dione
chebi:5385 ,
CHEMBL331627 ,
HMS1792M19
CCG-36058
CCG-35318
4-27-00-08902 (beilstein handbook reference)
5l648ph06k ,
unii-5l648ph06k
(3r,5as,6s,10ar)-6-hydroxy-3-(hydroxymethyl)-2-methyl-2,3,6,10-tetrahydro-5ah-3,10a-epidithiopyrazino[1,2-a]indole-1,4-dione
PI129
SCHEMBL54420
(3r,5as,6s,10ar)-2,3,5a,6-tetrahydro-6-hydroxy-3-(hydroxymethyl)-2-methyl-10h-3,10a-epidithiopyrazino[1,2-a]indole-1,4-dione
gliotoxin [mi]
10h-3,10a-epidithiopyrazino(1,2-a)indole-1,4-dione, 2,3,5a,6-tetrahydro-6-hydroxy-3-(hydroxymethyl)-2-methyl-, (3r,5as,6s,10ar)-
s. n.-12870
HB4612
(3r,5as,6s,10ar)-2,3,5a,6-tetrahydr o-6-hydroxy-3-(hydroxymethyl)-2-methyl-10h-3,10a-e pidithiopyrazino[1,2-a]indole-1,4-dione
AC-31273
AKOS024457211
HMS3403M19
mfcd00058534
sr-05000002340
SR-05000002340-2
Q413364
CS-0029133
HY-N6727
(3r,5as,6s,10ar)-6-hydroxy-3-(hydroxymethyl)-2-methyl-2,3,5a,6-tetrahydro-10h-3,10a-epidithiopyrazino[1,2-a]indole-1,4-dione
F82160
DTXSID60877179
(1r,7s,8s,11r)-7-hydroxy-11-(hydroxymethyl)-15-methyl-12,13-dithia-9,15-diazatetracyclo[9.2.2.01,9.03,8]pentadeca-3,5-diene-10,14-dione
BG162731
2,3,5a,6-tetrahydro-6-hydroxy-3-(hydroxymethyl)-2-methyl-10h-3,10a-epidithiopyrazino[1,2-a]indole-1,4 dione

Research Excerpts

Overview

Gliotoxin (GT) is a secondary fungal metabolite with pleiotropic immunosuppressive properties that have been implicated in Aspergillus virulence. Gliotoxin is a natural compound which has exhibited anti-tumor properties in multiple cancers, however, studies of the effect of gliotoxin on esophageal cancer are lacking.

ExcerptReferenceRelevance
"Gliotoxin (GT) is a secondary fungal metabolite with pleiotropic immunosuppressive properties that have been implicated in Aspergillus virulence. "( Genomewide screening for genes associated with gliotoxin resistance and sensitivity in Saccharomyces cerevisiae.
Albert, ND; Chamilos, G; Kontoyiannis, DP; Lamaris, GA; Lewis, RE, 2008
)
2.05
"Gliotoxin is a kind of epipolythiodioxopiperazine derived from different fungi that is characterized by a disulfide bridge. "( The Toxic Mechanism of Gliotoxins and Biosynthetic Strategies for Toxicity Prevention.
Liu, T; Ye, W; Zhang, W, 2021
)
2.37
"Gliotoxin is a natural compound which has exhibited anti-tumor properties in multiple cancers, however, studies of the effect of gliotoxin on esophageal cancer are lacking. "( Gliotoxin Induced Ferroptosis by Downregulating SUV39H1 Expression in Esophageal Cancer Cells.
Guo, J; Tong, L; Zhang, H; Zhang, L; Zhang, S, 2023
)
3.8
"Gliotoxin is a representative compound of the epipolythiodioxopiperazine (ETP) class of fungal metabolites. "( 6-Heterocyclic carboxylic ester derivatives of gliotoxin lead to LSD1 inhibitors in gastric cancer cells.
Chen, H; Fu, L; Ge, M; Li, H; Li, Y; Li, Z; Liu, H; Shan, L; Sun, Y, 2023
)
2.61
"Gliotoxin is an important epipolythiodioxopiperazine, which was biosynthesized by the "( Interaction of a Novel Zn2Cys6 Transcription Factor DcGliZ with Promoters in the Gliotoxin Biosynthetic Gene Cluster of the Deep-Sea-Derived Fungus
Huang, ZL; Kong, YL; Li, SN; Liu, S; Ye, W; Zhang, WM; Zhu, MZ, 2019
)
2.18
"Gliotoxin is a marine-derived fungal secondary metabolite with multiple biological activities, including immunosuppression, cytotoxicity, and et al."( Identification of Gliotoxin isolated from marine fungus as a new pyruvate kinase M2 inhibitor.
Gu, QQ; Li, DH; Li, J; Liu, ZL; Mai, XY; Qi, X; Tang, W, 2020
)
1.61
"Gliotoxin (GT) is a SM that interferes with the function and recruitment of innate immune cells, which are essential for eliminating A."( The Aspergillus fumigatus transcription factor RglT is important for gliotoxin biosynthesis and self-protection, and virulence.
Almeida, F; Bowyer, P; Bromley, M; Colabardini, AC; de Assis, LJ; de Castro, PA; Demasi, M; Dong, Z; Dos Santos, RAC; Doyle, S; Ferreira Filho, JA; Goldman, GH; Hernández, DCR; Loures, FV; Netto, LES; Owens, RA; Pardeshi, L; Preite, NW; Pupo, MT; Ries, LNA; Rokas, A; Silva, LP; Steenwyk, JL; Tan, K; Wong, KH, 2020
)
1.51
"Gliotoxin is an epipolythiodioxopiperazine (ETP) class toxin, contains a disulfide bridge that mediates its toxic effects via redox cycling and is produced by the opportunistic fungal pathogen Aspergillus fumigatus. "( Dysregulated gliotoxin biosynthesis attenuates the production of unrelated biosynthetic gene cluster-encoded metabolites in Aspergillus fumigatus.
Dolan, SK; Doyle, S; Jones, GW, 2018
)
2.29
"Gliotoxin is a virulence factor of the human pathogen Aspergillus fumigatus, the leading cause of invasive aspergillosis. "( Reconstitution of Enzymatic Carbon-Sulfur Bond Formation Reveals Detoxification-Like Strategy in Fungal Toxin Biosynthesis.
Brakhage, AA; Chankhamjon, P; Dworschak, JD; Heinekamp, T; Hertweck, C; Scharf, DH; Scherlach, K, 2018
)
1.92
"Gliotoxin is an important virulence factor of Aspergillus fumigatus. "( GliA in Aspergillus fumigatus is required for its tolerance to gliotoxin and affects the amount of extracellular and intracellular gliotoxin.
Aoyagi, K; Bunsupa, S; Kamei, K; Muraosa, Y; Takino, M; Toyotome, T; Wang, DN; Watanabe, A; Wuren, T; Yamazaki, M, 2014
)
2.08
"Gliotoxin is a redox-active nonribosomal peptide produced by Aspergillus fumigatus. "( Regulation of nonribosomal peptide synthesis: bis-thiomethylation attenuates gliotoxin biosynthesis in Aspergillus fumigatus.
Dolan, SK; Doyle, S; Fitzpatrick, DA; Hammel, S; Jones, GW; O'Keeffe, G; Owens, RA, 2014
)
2.07
"Gliotoxin (GT) is a redox-active metabolite, produced by Aspergillus fumigatus, which inhibits the growth of other fungi. "( Quantitative proteomics reveals the mechanism and consequence of gliotoxin-mediated dysregulation of the methionine cycle in Aspergillus niger.
Bayram, Ö; Dolan, SK; Doyle, S; Jones, GW; Manzanares-Miralles, L; Sarikaya-Bayram, Ö; Smith, EB, 2016
)
2.11
"Gliotoxin is an epipolythiodioxopiperazine (ETP) class toxin, contains a disulfide bridge that mediates its toxic effects via redox cycling and is produced by the opportunistic fungal pathogen "( Structural, mechanistic and functional insight into gliotoxin
Blankenfeldt, W; Bock, T; Dolan, SK; Doyle, S; Hering, V; Jones, GW; Owens, RA, 2017
)
2.15
"Gliotoxin is a member of the epipolythiodioxopiperazine class of toxins and is both the major and the most potent toxin produced by Aspergillus fumigatus. "( What do we know about the role of gliotoxin in the pathobiology of Aspergillus fumigatus?
Kwon-Chung, KJ; Sugui, JA, 2009
)
2.07
"Gliotoxin is a virulence factor of the human pathogen Aspergillus fumigatus , the leading cause of invasive aspergillosis. "( A dedicated glutathione S-transferase mediates carbon-sulfur bond formation in gliotoxin biosynthesis.
Brakhage, AA; Chankhamjon, P; Habel, A; Heinekamp, T; Hertweck, C; Hortschansky, P; Remme, N; Scharf, DH; Scherlach, K, 2011
)
2.04
"Gliotoxin is a natural mycotoxin with immunosuppressive and antimicrobial activity. "( Gliotoxin is a dual inhibitor of farnesyltransferase and geranylgeranyltransferase I with antitumor activity against breast cancer in vivo.
Brooke, G; Coombes, RC; Inman, L; Mirsaidi, N; Moody, CJ; Pace, P; Sun, C; Vigushin, DM, 2004
)
3.21
"Gliotoxin (GT) is a hydrophobic fungal metabolite of the epipolythiodioxopiperazine group which reacts with membrane thiols. "( Gliotoxin induces Mg2+ efflux from intact brain mitochondria.
Bozac, A; Salvi, M; Toninello, A, 2004
)
3.21
"Gliotoxins are a group of amino acids that are toxic to astrocytes, and are substrates of high-affinity sodium-dependent glutamate transporters. "( Gliotoxins disrupt alanine metabolism and glutathione production in C6 glioma cells: a 13C NMR spectroscopic study.
Brennan, L; Hewage, C; Malthouse, JP; McBean, GJ, 2004
)
3.21
"Gliotoxin is an immunosuppressive agent previously implicated in assisting tissue penetration."( Correlation between gliotoxin production and virulence of Aspergillus fumigatus in Galleria mellonella.
Doyle, S; Kavanagh, K; Messina, CG; Reeves, EP, 2004
)
1.37
"Gliotoxin is a mycotoxin from the epipolythiodioxypipeazine family with biological active internal disulfide bridge. "( [Chemistry and biological effects of gliotoxin].
Kosalec, I; Pepeljnjak, S, 2004
)
2.04
"Gliotoxin is a secondary metabolite produced by several fungi including the opportunistic animal pathogen Aspergillus fumigatus. "( Bioinformatic and expression analysis of the putative gliotoxin biosynthetic gene cluster of Aspergillus fumigatus.
Gardiner, DM; Howlett, BJ, 2005
)
2.02
"Gliotoxin is a secondary metabolite of the epipolythiodioxopiperazine family with biologically active internal disulfide bridge. "( Influence of media and temperature on gliotoxin production in Aspergillus fumigatus strains.
Jandrlić, M; Kosalec, I; Pepeljnjak, S, 2005
)
2.04
"Gliotoxin is an immunosuppressive cytotoxin produced by numerous environmental or pathogenic fungal species. "( A new and rapid bioassay for the detection of gliotoxin and related epipolythiodioxopiperazines produced by fungi.
Grovel, O; Kerzaon, I; Petit, K; Pouchus, YF; Robiou Du Pont, T, 2006
)
2.03
"Gliotoxin is a fungal second metabolite produced by diverse species that can be found in compost, stored crops, moist animal feed and sawdust. "( Glutathione intensifies gliotoxin-induced cytotoxicity in human neuroblastoma SH-SY5Y cells.
Axelsson, V; Forsby, A; Pikkarainen, K, 2006
)
2.08
"Gliotoxin is a secondary metabolite produced by several fungi including the opportunistic human pathogen Aspergillus fumigatus. "( Deletion of the gliP gene of Aspergillus fumigatus results in loss of gliotoxin production but has no effect on virulence of the fungus in a low-dose mouse infection model.
Brakhage, AA; Geginat, G; Härtl, A; Heinekamp, T; Hof, H; Kupfahl, C; Ruppert, T, 2006
)
2.01
"Gliotoxin is a nonribosomal peptide produced by Aspergillus fumigatus. "( GliZ, a transcriptional regulator of gliotoxin biosynthesis, contributes to Aspergillus fumigatus virulence.
Andes, D; Balajee, SA; Bok, JW; Chung, D; Frisvad, JC; Keller, NP; Kirby, KA; Marr, KA; Nielsen, KF, 2006
)
2.05
"Gliotoxin is an immunosuppressive apoptogenic mycotoxin produced by a number of fungi including important human pathogens as Aspergillus fumigatus. "( Gliotoxin-mediated suppression of innate and adaptive immune functions directed against Listeria monocytogenes.
Geginat, G; Hof, H; Kupfahl, C, 2006
)
3.22
"Gliotoxin is a mycotoxin having a considerable number of immuno-suppressive actions and is produced by several moulds such as Aspergillus fumigatus. "( Gliotoxin from Aspergillus fumigatus affects phagocytosis and the organization of the actin cytoskeleton by distinct signalling pathways in human neutrophils.
André, K; Collet, X; Coméra, C; Galtier, P; Laffitte, J; Maridonneau-Parini, I, 2007
)
3.23
"Gliotoxin is an immunosuppressive mycotoxin long suspected to be a potential virulence factor of Aspergillus fumigatus. "( Gliotoxin is a virulence factor of Aspergillus fumigatus: gliP deletion attenuates virulence in mice immunosuppressed with hydrocortisone.
Chang, YC; Gallin, JI; Galvez, EM; Kwon-Chung, KJ; Müllbacher, A; Nardone, G; Pardo, J; Simon, MM; Sugui, JA; Zarember, KA, 2007
)
3.23
"Gliotoxin is a epipolythiodioxopiperazine toxin that is made by the filamentous fungus Aspergillus fumigatus. "( Gliotoxin production in Aspergillus fumigatus contributes to host-specific differences in virulence.
Chamilos, G; Chiang, LY; Ejzykowicz, DE; Filler, SG; Jacobson, RH; Kontoyiannis, DP; May, GS; Nguyen, CK; Spikes, S; Xu, R, 2008
)
3.23
"Gliotoxin is an immunosuppressive secondary metabolite produced by several pathogenic fungi. "( Investigation of the potential use of immunosuppressive agent gliotoxin in organ transplantation.
Hutchinson, IV; Moreland, A; Müllbacher, A; Sutton, P, 1995
)
1.97
"Gliotoxin is an epidithiodioxopiperazine compound which can both react with sulfhydryl groups and form hydrogen peroxide. "( Gliotoxin stimulates Ca2+ release from intact rat liver mitochondria.
Richter, C; Schweizer, M, 1994
)
3.17
"Gliotoxin is a secondary metabolite produced by several pathogenic fungi. "( Evidence that gliotoxin enhances lymphocyte activation and induces apoptosis by effects on cyclic AMP levels.
Beaver, J; Sutton, P; Waring, P, 1995
)
2.09
"Gliotoxin is a toxic metabolite of Aspergillus fumigatus Fresenius and other fungi. "( Determination of optimum growth conditions for gliotoxin production by Aspergillus fumigatus and development of a novel method for gliotoxin detection.
Barton, RC; Belkacemi, L; Evans, EG; Hopwood, V, 1999
)
2
"Gliotoxin is a toxic epipolythiodioxopiperazine metabolite produced by the pathogens."( Gliotoxin-induced cytotoxicity proceeds via apoptosis and is mediated by caspases and reactive oxygen species in LLC-PK1 cells.
Goping, G; Hirszel, P; Zhao, A; Zhou, X, 2000
)
2.47
"Gliotoxin is a fungal metabolite that has immunosuppressive properties. "( In vitro and in vivo effects of gliotoxin, a fungal metabolite: efficacy against dextran sodium sulfate-induced colitis in rats.
Fitzpatrick, LR; Le, T; Wang, J, 2000
)
2.03
"Gliotoxin is a fungal metabolite that has immunosuppressive properties. "( Gliotoxin, an inhibitor of nuclear factor-kappa B, attenuates peptidoglycan-polysaccharide-induced colitis in rats.
Fitzpatrick, LR; Le, T; Wang, J, 2002
)
3.2
"Gliotoxin itself proved to be a potent inhibitor of protein synthesis."( DNA fragmentation induced in macrophages by gliotoxin does not require protein synthesis and is preceded by raised inositol triphosphate levels.
Waring, P, 1990
)
1.26
"Gliotoxin is a member of the epipolythiodioxopiperazine (ETP) group of fungal metabolites, derived from the human pathogen Aspergillus fumigatus."( Langerhans cell depletion in gliotoxin-treated murine epidermis.
Halliday, GM; McMinn, PC; Muller, HK; Waring, P, 1991
)
1.29
"Gliotoxin is a fungal metabolite belonging to the class of epipolythiodioxopiperazines which possesses both immunomodulating and anti-phagocytic activities. "( Replication of donor lymphocytes in recipients is not essential for the passive transfer of allergic encephalomyelitis.
Eichner, RD; Müllbacher, A; Waring, P; Willenborg, DO, 1988
)
1.72
"Gliotoxin (GT) is a fungal metabolite that reduces the ability of murine macrophages to react immunologically in vitro. "( Immunomodulation of human fetal cells by the fungal metabolite gliotoxin.
Lissing, JR; Suranyi, MG; Tuch, BE, 1988
)
1.96

Effects

Gliotoxin was discarded from clinical practice due to its toxicity. Gliotoxin has a wide range of effects on metazoan cells in culture, including induction of apoptosis.

Gliotoxin has been used to treat murine allogeneic bone marrow prior to transplantation into irradiated recipients. In this situation the drug prevents development of graft-versus-host disease. Gliotoxin was discarded from clinical practice due to its toxicity.

ExcerptReferenceRelevance
"Gliotoxin has an antibacterial and antiviral activity, but it was discarded from clinical practice due to its toxicity."( [Chemistry and biological effects of gliotoxin].
Kosalec, I; Pepeljnjak, S, 2004
)
1.32
"Gliotoxin has a wide range of effects on metazoan cells in culture, including induction of apoptosis through inhibition of Nf-kappaB, and inhibition of superoxide production by phagocytes."( Gliotoxin production in Aspergillus fumigatus contributes to host-specific differences in virulence.
Chamilos, G; Chiang, LY; Ejzykowicz, DE; Filler, SG; Jacobson, RH; Kontoyiannis, DP; May, GS; Nguyen, CK; Spikes, S; Xu, R, 2008
)
2.51
"Gliotoxin has been well-known as an inhibitor of NF-κB activation, though its action mechanism has remained elusive."( Gliotoxin suppresses NF-κB activation by selectively inhibiting linear ubiquitin chain assembly complex (LUBAC).
Egashira, S; Hanaoka, K; Iwai, K; Kirisako, T; Kojima, H; Komatsu, T; Matsumoto, T; Miller, S; Nagano, T; Okabe, T; Saito, N; Sakamoto, H; Sasaki, Y; Shimonishi, M; Terai, T; Ueno, T; Wakatsuki, S, 2015
)
2.58
"Gliotoxin has been shown to promote a reversal of liver fibrosis in an animal model of the disease although its mechanism of action in the liver is poorly defined. "( Mechanism of action of the antifibrogenic compound gliotoxin in rat liver cells.
Cameron, GA; Elrick, LJ; Halestrap, AP; Haughton, EL; Hawksworth, GM; Leel, V; Marek, CJ; Orr, JG; Trim, JE; Wright, MC, 2004
)
2.02
"Gliotoxin has an antibacterial and antiviral activity, but it was discarded from clinical practice due to its toxicity."( [Chemistry and biological effects of gliotoxin].
Kosalec, I; Pepeljnjak, S, 2004
)
1.32
"Gliotoxin has a wide range of effects on metazoan cells in culture, including induction of apoptosis through inhibition of Nf-kappaB, and inhibition of superoxide production by phagocytes."( Gliotoxin production in Aspergillus fumigatus contributes to host-specific differences in virulence.
Chamilos, G; Chiang, LY; Ejzykowicz, DE; Filler, SG; Jacobson, RH; Kontoyiannis, DP; May, GS; Nguyen, CK; Spikes, S; Xu, R, 2008
)
2.51
"Gliotoxin has previously been used to treat murine allogeneic bone marrow prior to transplantation into irradiated recipients, and in this situation the drug prevents development of graft-versus-host disease, and permits the establishment of allogeneic bone marrow chimeras."( Gliotoxin treatment selectively spares M-CSF- plus IL-3-responsive multipotent haemopoietic progenitor cells in bone marrow.
Hapel, AJ; Kobayashi, M; Müllbacher, A; Waring, P, 1991
)
2.45

Actions

Gliotoxin can inhibit alcohol dehydrogenase by either pathway. This will depend on the availability of reducing agents such as glutathione and/or how readily the reactive oxygen species generated are removed.

ExcerptReferenceRelevance
"Gliotoxin can therefore inhibit alcohol dehydrogenase by either pathway and this will depend on the availability of reducing agents such as glutathione and/or how readily the reactive oxygen species generated are removed."( Gliotoxin inactivates alcohol dehydrogenase by either covalent modification or free radical damage mediated by redox cycling.
Lin, QH; Sjaarda, A; Waring, P, 1995
)
2.46
"Gliotoxin was found to cause substantial double-stranded DNA breakage in spleen cells which was dose- and time-dependent."( The immunomodulating agent gliotoxin causes genomic DNA fragmentation.
Braithwaite, AW; Eichner, RD; Müllbacher, A; Waring, P, 1987
)
1.29

Treatment

Giotoxin treatment resulted in a significant decrease in liver fibrosis in rats, but did not improve liver functions. Gliotoxin-TNF-alpha cotreatment induced massive apoptosis in these otherwise TNF- alpha-resistant cell lines.

ExcerptReferenceRelevance
"Gliotoxin+shikonin co-treatment did not increase S or G"( Combination Treatment Using Pyruvate Kinase M2 Inhibitors for the Sensitization of High Density Triple-negative Breast Cancer Cells.
Han, JH; Kim, HS; Lee, JS; Oh, Y; Park, JH; Shin, JK; Yoon, S,
)
0.85
"Gliotoxin treatment also induced an irreversible EFF transformation in a dose/time-dependent manner."( The fungal metabolite gliotoxin inhibits proteasome proteolytic activity and induces an irreversible pseudocystic transformation and cell death in Tritrichomonas foetus.
Benchimol, M; Menna-Barreto, RF; Pereira-Neves, A, 2016
)
1.47
"Gliotoxin treatment resulted in a significant decrease in liver fibrosis in rats, but did not improve liver functions."( Gliotoxin ameliorates development of fibrosis and cirrhosis in a thioacetamide rat model.
Brazovsky, E; Brill, S; Dekel, R; Halpern, Z; Oren, R; Zvibel, I, 2003
)
2.48
"Gliotoxin treatment for 6 or 24 h caused cell viability to decrease in a dose-dependent manner, with effective concentrations (EC50s) being similar for the three cell lines but varying with exposure time."( Gliotoxin-induced cytotoxicity in three salmonid cell lines: cell death by apoptosis and necrosis.
Bols, NC; DeWitte-Orr, SJ, 2005
)
2.49
"Gliotoxin-TNF-alpha cotreatment induced massive apoptosis in these otherwise TNF-alpha-resistant cell lines."( NF-kappaB determines between apoptosis and proliferation in hepatocytes during liver regeneration.
Bock, CT; Malek, NP; Manns, MP; Plümpe, J; Rakemann, T; Trautwein, C, 2000
)
1.03
"Gliotoxin treatment dose-dependently down-regulated colonic inflammation as assessed histologically and in parallel there was a suppression of colonic TNF-alpha and IL-1alpha mRNA expression on day 8 as analysed by semiquantitative reverse transcriptase-polymerase chain reaction (P < 0.01)."( Nuclear factor-kappa B activity and intestinal inflammation in dextran sulphate sodium (DSS)-induced colitis in mice is suppressed by gliotoxin.
Brand, K; Falk, W; Herfarth, H; Rath, HC; Rogler, G; Schölmerich, J, 2000
)
1.23
"Gliotoxin treatment significantly reduced the number of activated stellate cells and mean thickness of bridging fibrotic septae in livers from rats treated with carbon tetrachloride."( Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats.
Arthur, MJ; Iredale, JP; Issa, R; Mann, DA; Murray, GI; Primrose, JN; Smart, DE; Trim, N; Wright, MC, 2001
)
2.47
"Gliotoxin-treated rats also had partially normalized biochemical indices of colitis, such as colonic cytokine levels."( Gliotoxin, an inhibitor of nuclear factor-kappa B, attenuates peptidoglycan-polysaccharide-induced colitis in rats.
Fitzpatrick, LR; Le, T; Wang, J, 2002
)
2.48
"Gliotoxin treatment of lymph node cell-enriched bone marrow significantly delayed the onset of graft-versus-host disease in fully allogeneic bone marrow chimeras."( Selective resistance of bone marrow-derived hemopoietic progenitor cells to gliotoxin.
Braithwaite, AW; Eichner, RD; Hume, D; Müllbacher, A; Waring, P, 1987
)
1.22
"Gliotoxin treatment of bone marrow allows the establishment of fully allogenic bone marrow chimeras free of GVH disease."( Prevention of graft-versus-host disease by treatment of bone marrow with gliotoxin in fully allogeneic chimeras and their cytotoxic T cell repertoire.
Eichner, RD; Moreland, AF; Müllbacher, A; Sjaarda, A; Waring, P, 1988
)
1.23
"Pretreatment with gliotoxin significantly reduced the number of HSCs in the liver and further suppressed liver injury following I/R. "( Hepatic Stellate Cells Play a Functional Role in Exacerbating Ischemia-Reperfusion Injury in Rat Liver.
Motoyama, S; Nakagawa, Y; Otsuka, N; Takahashi, T; Uchinami, H; Yamamoto, Y; Yoshioka, M, 2019
)
0.85

Toxicity

Gliotoxin is a toxic epipolythiodioxopiperazine metabolite produced by the pathogens. The role of glutathione in gliotoxin-induced toxicity was studied to elucidate the toxic mechanisms leading to neurite degeneration.

ExcerptReferenceRelevance
" Gliotoxin is a toxic epipolythiodioxopiperazine metabolite produced by the pathogens."( Gliotoxin-induced cytotoxicity proceeds via apoptosis and is mediated by caspases and reactive oxygen species in LLC-PK1 cells.
Goping, G; Hirszel, P; Zhao, A; Zhou, X, 2000
)
2.66
" The most toxic MVOC was 1-decanol which was as effective as MMS in all test systems."( On the cytotoxicity of some microbial volatile organic compounds as studied in the human lung cell line A549.
Kreja, L; Seidel, HJ, 2002
)
0.31
" The role of glutathione in gliotoxin-induced toxicity was studied in order to elucidate the toxic mechanisms leading to neurite degeneration and cell death in differentiated human neuroblastoma (SH-SY5Y) cells."( Glutathione intensifies gliotoxin-induced cytotoxicity in human neuroblastoma SH-SY5Y cells.
Axelsson, V; Forsby, A; Pikkarainen, K, 2006
)
0.93
" They are not only different in the strength of their toxic effects but also in a variety of physiological aspects."( Cytotoxicity assessment of gliotoxin and penicillic acid in Tetrahymena pyriformis.
Gräbsch, C; Herbarth, O; Loffhagen, N; Müller, A; Wichmann, G, 2006
)
0.63
" As model toxic compounds lipopolysaccharide (LPS, inducing inflammation), paracetamol (necrosis), carbon tetrachloride (CCl(4), fibrosis and necrosis) and gliotoxin (apoptosis) were used."( Microarray analysis in rat liver slices correctly predicts in vivo hepatotoxicity.
Bauerschmidt, S; Draaisma, AL; Elferink, MG; Groothuis, GM; Merema, MT; Olinga, P; Polman, J; Schoonen, WG, 2008
)
0.54

Dosage Studied

Gliotoxin significantly decreased the number of GFAP-positive cells 48 h after dosing (2. mg/kg/day) concentration of gliotoxin found in infected tissue did not appear to be correlated with the dosage of organism given. In vitro, all compounds demonstrated growth inhibition at a dose-response manner.

ExcerptRelevanceReference
" The concentration of gliotoxin found in infected tissue did not appear to be correlated with the dosage of organism given."( Production of gliotoxin during the pathogenic state in turkey poults by Aspergillus fumigatus Fresenius.
DeBey, MC; Richard, JL, 1995
)
0.97
" In vitro, all compounds demonstrated growth inhibition at a dose-response manner; however, manumycin, gliotoxin, and DHEA demonstrated an initial increase in growth rate at lower doses."( Chemopreventive efficacy of promising farnesyltransferase inhibitors.
Crist, KA; Hara, M; Lantry, LE; Lubet, RA; Wang, Y; You, M; Zeeck, A; Zhang, Z, 2000
)
0.52
" Gliotoxin (2 mg/kg/day) was dosed from day 14 after the initial intramural colonic injection of peptidoglycan-polysaccharide until day 21."( Gliotoxin, an inhibitor of nuclear factor-kappa B, attenuates peptidoglycan-polysaccharide-induced colitis in rats.
Fitzpatrick, LR; Le, T; Wang, J, 2002
)
2.67
" Either a low uptake of the compounds in the cells that cause disease might account for this lack of effect, or side-effects in other cells may limit the dosage of the drugs."( Targeting hepatic stellate cells for cell-specific treatment of liver fibrosis.
Beljaars, L; Meijer, DK; Poelstra, K, 2002
)
0.31
" Results were measured with a fluorescent multiwell plate reader and dose-response curves were obtained successfully with both procedures."( Comparing a ciliate and a fish cell line for their sensitivity to several classes of toxicants by the novel application of multiwell filter plates to Tetrahymena.
Bols, NC; Dayeh, VR; DeWitte-Orr, SJ; Grominsky, S; Lee, LE; Lynn, DH; Sotornik, D; Yeung, CR,
)
0.13
" The A549 cells display a dose-response relationship to each toxin with initial responses including alterations in metabolic activity, increases in membrane permeability, and initiation of response genes."( Alterations of A549 lung cell gene expression in response to biochemical toxins.
Boesewetter, DE; Collier, JL; Kim, AM; Riley, MR, 2006
)
0.33
" Using Tetrahymena pyriformis, a single-cell organism well established as a suitable model for human respiratory epithelium-cell functionalities, we investigated dose-response relationships of the mycotoxins gliotoxin and penicillic acid."( Cytotoxicity assessment of gliotoxin and penicillic acid in Tetrahymena pyriformis.
Gräbsch, C; Herbarth, O; Loffhagen, N; Müller, A; Wichmann, G, 2006
)
0.82
" To better understand the contributions of different signaling pathways, the expression and role of Ras activation was evaluated after oral dosing of mice with APAP (400-500 mg/kg)."( Farnesyltransferase inhibitors reduce Ras activation and ameliorate acetaminophen-induced liver injury in mice.
Nandi, D; Saha, B, 2009
)
0.35
"Gliotoxin significantly decreased the number of GFAP-positive cells 48 h after dosing (2."( Hepatic Stellate Cells Play a Functional Role in Exacerbating Ischemia-Reperfusion Injury in Rat Liver.
Motoyama, S; Nakagawa, Y; Otsuka, N; Takahashi, T; Uchinami, H; Yamamoto, Y; Yoshioka, M, 2019
)
1.96
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (5)

RoleDescription
mycotoxinPoisonous substance produced by fungi.
immunosuppressive agentAn agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response.
EC 2.5.1.58 (protein farnesyltransferase) inhibitorAn EC 2.5.1.* (non-methyl-alkyl or aryl transferase) inhibitor that interferes with the action of protein farnesyltransferase (EC 2.5.1.58), one of the three enzymes in the prenyltransferase group.
proteasome inhibitorA drug that blocks the action of proteasomes, cellular complexes that break down proteins.
antifungal agentAn antimicrobial agent that destroys fungi by suppressing their ability to grow or reproduce.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (4)

ClassDescription
organic disulfideCompounds of structure RSSR in which R and R' are organic groups.
pyrazinoindoleAn organic heterotricyclic compound comprising a pyrazine ring fused to an indole ring system.
organic heterotetracyclic compound
dipeptideAny molecule that contains two amino-acid residues connected by peptide linkages.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (16)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Putative fructose-1,6-bisphosphate aldolaseGiardia intestinalisPotency22.33420.140911.194039.8107AID2451
phosphopantetheinyl transferaseBacillus subtilisPotency2.51190.141337.9142100.0000AID1490
vitamin D3 receptor isoform VDRAHomo sapiens (human)Potency3.98110.354828.065989.1251AID504847
nuclear receptor ROR-gamma isoform 1Mus musculus (house mouse)Potency0.04470.00798.23321,122.0200AID2551
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Histone-lysine N-methyltransferase SUV39H1Homo sapiens (human)IC50 (µMol)0.26000.06600.51401.2000AID700488
Acetolactate synthase catalytic subunit, mitochondrialSaccharomyces cerevisiae S288CIC50 (µMol)0.20000.20000.20000.2000AID475997
Pyruvate kinase PKMHomo sapiens (human)IC50 (µMol)22.64000.50002.788610.0000AID1881910
Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaHomo sapiens (human)IC50 (µMol)32.70000.00050.471610.0000AID73280; AID73585; AID74786
Protein farnesyltransferase subunit betaHomo sapiens (human)IC50 (µMol)40.55000.00050.21772.5000AID73280; AID73585
Geranylgeranyl transferase type-1 subunit betaHomo sapiens (human)IC50 (µMol)17.00000.00732.364210.0000AID74786
Mycothiol S-conjugate amidaseMycobacterium tuberculosis H37RvIC50 (µMol)50.00002.80002.80002.8000AID475995
Cysteine protease Trypanosoma brucei rhodesienseIC50 (µMol)50.00000.00313.87667.7500AID475976
E3 ubiquitin-protein ligase RNF31Homo sapiens (human)IC50 (µMol)0.51000.51000.51000.5100AID1371346
Histone-lysine N-methyltransferase EHMT2Homo sapiens (human)IC50 (µMol)3.46500.00251.14809.2000AID646185; AID700489
RanBP-type and C3HC4-type zinc finger-containing protein 1Homo sapiens (human)IC50 (µMol)0.51000.51000.51000.5100AID1371346
SharpinHomo sapiens (human)IC50 (µMol)0.51000.51000.51000.5100AID1371346
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (71)

Processvia Protein(s)Taxonomy
negative regulation of transcription by RNA polymerase IIHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
DNA damage responseHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
cellular response to hypoxiaHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
rDNA heterochromatin formationHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
chromatin organizationHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
rRNA processingHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
circadian rhythmHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
cell differentiationHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
methylationHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
cellular response to glucose starvationHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
epigenetic programming in the zygotic pronucleiHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
negative regulation of cell cycleHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
negative regulation of DNA-templated transcriptionHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
regulation of transcription by glucoseHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
energy homeostasisHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
programmed cell deathPyruvate kinase PKMHomo sapiens (human)
canonical glycolysisPyruvate kinase PKMHomo sapiens (human)
positive regulation of sprouting angiogenesisPyruvate kinase PKMHomo sapiens (human)
positive regulation of cytoplasmic translationPyruvate kinase PKMHomo sapiens (human)
glycolytic processPyruvate kinase PKMHomo sapiens (human)
cellular response to insulin stimulusPyruvate kinase PKMHomo sapiens (human)
transforming growth factor beta receptor signaling pathwayProtein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaHomo sapiens (human)
protein farnesylationProtein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaHomo sapiens (human)
protein geranylgeranylationProtein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaHomo sapiens (human)
positive regulation of Rac protein signal transductionProtein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaHomo sapiens (human)
skeletal muscle acetylcholine-gated channel clusteringProtein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaHomo sapiens (human)
positive regulation of tubulin deacetylationProtein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaHomo sapiens (human)
positive regulation of deacetylase activityProtein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaHomo sapiens (human)
positive regulation of skeletal muscle acetylcholine-gated channel clusteringProtein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaHomo sapiens (human)
lipid metabolic processProtein farnesyltransferase subunit betaHomo sapiens (human)
protein farnesylationProtein farnesyltransferase subunit betaHomo sapiens (human)
protein geranylgeranylationGeranylgeranyl transferase type-1 subunit betaHomo sapiens (human)
protein polyubiquitinationE3 ubiquitin-protein ligase RNF31Homo sapiens (human)
CD40 signaling pathwayE3 ubiquitin-protein ligase RNF31Homo sapiens (human)
defense response to bacteriumE3 ubiquitin-protein ligase RNF31Homo sapiens (human)
positive regulation of canonical NF-kappaB signal transductionE3 ubiquitin-protein ligase RNF31Homo sapiens (human)
T cell receptor signaling pathwayE3 ubiquitin-protein ligase RNF31Homo sapiens (human)
positive regulation of NF-kappaB transcription factor activityE3 ubiquitin-protein ligase RNF31Homo sapiens (human)
negative regulation of necroptotic processE3 ubiquitin-protein ligase RNF31Homo sapiens (human)
protein linear polyubiquitinationE3 ubiquitin-protein ligase RNF31Homo sapiens (human)
positive regulation of protein targeting to mitochondrionE3 ubiquitin-protein ligase RNF31Homo sapiens (human)
positive regulation of xenophagyE3 ubiquitin-protein ligase RNF31Homo sapiens (human)
negative regulation of transcription by RNA polymerase IIHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
cellular response to starvationHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
regulation of DNA replicationHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
DNA methylation-dependent heterochromatin formationHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
synaptonemal complex assemblyHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
spermatid developmentHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
long-term memoryHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
fertilizationHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
peptidyl-lysine dimethylationHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
regulation of protein modification processHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
organ growthHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
phenotypic switchingHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
negative regulation of gene expression via chromosomal CpG island methylationHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
response to ethanolHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
behavioral response to cocaineHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
oocyte developmentHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
neuron fate specificationHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
response to fungicideHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
cellular response to cocaineHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
cellular response to xenobiotic stimulusHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
negative regulation of autophagosome assemblyHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
negative regulation of transcription by RNA polymerase IIHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
protein polyubiquitinationRanBP-type and C3HC4-type zinc finger-containing protein 1Homo sapiens (human)
positive regulation of metabolic processRanBP-type and C3HC4-type zinc finger-containing protein 1Homo sapiens (human)
negative regulation of NF-kappaB transcription factor activityRanBP-type and C3HC4-type zinc finger-containing protein 1Homo sapiens (human)
defense response to bacteriumRanBP-type and C3HC4-type zinc finger-containing protein 1Homo sapiens (human)
positive regulation of canonical NF-kappaB signal transductionRanBP-type and C3HC4-type zinc finger-containing protein 1Homo sapiens (human)
proteasome-mediated ubiquitin-dependent protein catabolic processRanBP-type and C3HC4-type zinc finger-containing protein 1Homo sapiens (human)
T cell receptor signaling pathwayRanBP-type and C3HC4-type zinc finger-containing protein 1Homo sapiens (human)
positive regulation of NF-kappaB transcription factor activityRanBP-type and C3HC4-type zinc finger-containing protein 1Homo sapiens (human)
negative regulation of necroptotic processRanBP-type and C3HC4-type zinc finger-containing protein 1Homo sapiens (human)
protein linear polyubiquitinationRanBP-type and C3HC4-type zinc finger-containing protein 1Homo sapiens (human)
positive regulation of non-canonical NF-kappaB signal transductionRanBP-type and C3HC4-type zinc finger-containing protein 1Homo sapiens (human)
positive regulation of extrinsic apoptotic signaling pathwayRanBP-type and C3HC4-type zinc finger-containing protein 1Homo sapiens (human)
mitochondrion organizationSharpinHomo sapiens (human)
regulation of tumor necrosis factor-mediated signaling pathwaySharpinHomo sapiens (human)
apoptotic nuclear changesSharpinHomo sapiens (human)
keratinizationSharpinHomo sapiens (human)
defense response to bacteriumSharpinHomo sapiens (human)
positive regulation of canonical NF-kappaB signal transductionSharpinHomo sapiens (human)
negative regulation of inflammatory responseSharpinHomo sapiens (human)
protein linear polyubiquitinationSharpinHomo sapiens (human)
regulation of CD40 signaling pathwaySharpinHomo sapiens (human)
proteasome-mediated ubiquitin-dependent protein catabolic processSharpinHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (49)

Processvia Protein(s)Taxonomy
transcription cis-regulatory region bindingHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
chromatin bindingHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
protein bindingHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
zinc ion bindingHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
S-adenosylmethionine-dependent methyltransferase activityHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
histone methyltransferase activityHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
histone H3K9 methyltransferase activityHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
histone H3 methyltransferase activityHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
histone H3K9 trimethyltransferase activityHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
magnesium ion bindingPyruvate kinase PKMHomo sapiens (human)
RNA bindingPyruvate kinase PKMHomo sapiens (human)
mRNA bindingPyruvate kinase PKMHomo sapiens (human)
protein tyrosine kinase activityPyruvate kinase PKMHomo sapiens (human)
pyruvate kinase activityPyruvate kinase PKMHomo sapiens (human)
protein bindingPyruvate kinase PKMHomo sapiens (human)
ATP bindingPyruvate kinase PKMHomo sapiens (human)
MHC class II protein complex bindingPyruvate kinase PKMHomo sapiens (human)
potassium ion bindingPyruvate kinase PKMHomo sapiens (human)
cadherin bindingPyruvate kinase PKMHomo sapiens (human)
protein farnesyltransferase activityProtein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaHomo sapiens (human)
protein farnesyltransferase activityProtein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaHomo sapiens (human)
protein geranylgeranyltransferase activityProtein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaHomo sapiens (human)
Rab geranylgeranyltransferase activityProtein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaHomo sapiens (human)
protein bindingProtein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaHomo sapiens (human)
microtubule bindingProtein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaHomo sapiens (human)
receptor tyrosine kinase bindingProtein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaHomo sapiens (human)
alpha-tubulin bindingProtein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaHomo sapiens (human)
molecular adaptor activityProtein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaHomo sapiens (human)
CAAX-protein geranylgeranyltransferase activityProtein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaHomo sapiens (human)
protein farnesyltransferase activityProtein farnesyltransferase subunit betaHomo sapiens (human)
protein farnesyltransferase activityProtein farnesyltransferase subunit betaHomo sapiens (human)
protein bindingProtein farnesyltransferase subunit betaHomo sapiens (human)
zinc ion bindingProtein farnesyltransferase subunit betaHomo sapiens (human)
protein geranylgeranyltransferase activityGeranylgeranyl transferase type-1 subunit betaHomo sapiens (human)
CAAX-protein geranylgeranyltransferase activityGeranylgeranyl transferase type-1 subunit betaHomo sapiens (human)
protein bindingGeranylgeranyl transferase type-1 subunit betaHomo sapiens (human)
zinc ion bindingGeranylgeranyl transferase type-1 subunit betaHomo sapiens (human)
CAAX-protein geranylgeranyltransferase activityGeranylgeranyl transferase type-1 subunit betaHomo sapiens (human)
ubiquitin-protein transferase activityE3 ubiquitin-protein ligase RNF31Homo sapiens (human)
protein bindingE3 ubiquitin-protein ligase RNF31Homo sapiens (human)
zinc ion bindingE3 ubiquitin-protein ligase RNF31Homo sapiens (human)
ubiquitin protein ligase bindingE3 ubiquitin-protein ligase RNF31Homo sapiens (human)
identical protein bindingE3 ubiquitin-protein ligase RNF31Homo sapiens (human)
ubiquitin bindingE3 ubiquitin-protein ligase RNF31Homo sapiens (human)
ubiquitin protein ligase activityE3 ubiquitin-protein ligase RNF31Homo sapiens (human)
K48-linked polyubiquitin modification-dependent protein bindingE3 ubiquitin-protein ligase RNF31Homo sapiens (human)
linear polyubiquitin bindingE3 ubiquitin-protein ligase RNF31Homo sapiens (human)
K63-linked polyubiquitin modification-dependent protein bindingE3 ubiquitin-protein ligase RNF31Homo sapiens (human)
RNA polymerase II transcription regulatory region sequence-specific DNA bindingHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
transcription corepressor bindingHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
p53 bindingHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
protein bindingHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
zinc ion bindingHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
protein-lysine N-methyltransferase activityHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
enzyme bindingHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
histone H3K9 methyltransferase activityHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
histone H3K27 methyltransferase activityHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
C2H2 zinc finger domain bindingHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
histone H3K56 methyltransferase activityHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
histone H3K9me2 methyltransferase activityHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
promoter-specific chromatin bindingHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
ubiquitin-protein transferase activityRanBP-type and C3HC4-type zinc finger-containing protein 1Homo sapiens (human)
protein bindingRanBP-type and C3HC4-type zinc finger-containing protein 1Homo sapiens (human)
identical protein bindingRanBP-type and C3HC4-type zinc finger-containing protein 1Homo sapiens (human)
ubiquitin bindingRanBP-type and C3HC4-type zinc finger-containing protein 1Homo sapiens (human)
metal ion bindingRanBP-type and C3HC4-type zinc finger-containing protein 1Homo sapiens (human)
ubiquitin ligase activator activityRanBP-type and C3HC4-type zinc finger-containing protein 1Homo sapiens (human)
protein bindingSharpinHomo sapiens (human)
protein-macromolecule adaptor activitySharpinHomo sapiens (human)
polyubiquitin modification-dependent protein bindingSharpinHomo sapiens (human)
identical protein bindingSharpinHomo sapiens (human)
protein-containing complex bindingSharpinHomo sapiens (human)
metal ion bindingSharpinHomo sapiens (human)
ubiquitin-protein transferase activitySharpinHomo sapiens (human)
ubiquitin bindingSharpinHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (34)

Processvia Protein(s)Taxonomy
nucleusHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
chromosome, centromeric regionHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
condensed nuclear chromosomeHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
nucleusHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
nuclear laminaHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
nucleoplasmHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
nucleolusHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
plasma membraneHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
cytoplasmic vesicleHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
eNoSc complexHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
heterochromatinHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
chromatin silencing complexHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
rDNA heterochromatinHistone-lysine N-methyltransferase SUV39H1Homo sapiens (human)
extracellular regionPyruvate kinase PKMHomo sapiens (human)
nucleusPyruvate kinase PKMHomo sapiens (human)
cytoplasmPyruvate kinase PKMHomo sapiens (human)
mitochondrionPyruvate kinase PKMHomo sapiens (human)
rough endoplasmic reticulumPyruvate kinase PKMHomo sapiens (human)
cytosolPyruvate kinase PKMHomo sapiens (human)
ciliumPyruvate kinase PKMHomo sapiens (human)
vesiclePyruvate kinase PKMHomo sapiens (human)
secretory granule lumenPyruvate kinase PKMHomo sapiens (human)
collagen-containing extracellular matrixPyruvate kinase PKMHomo sapiens (human)
extracellular exosomePyruvate kinase PKMHomo sapiens (human)
extracellular vesiclePyruvate kinase PKMHomo sapiens (human)
ficolin-1-rich granule lumenPyruvate kinase PKMHomo sapiens (human)
cytoplasmPyruvate kinase PKMHomo sapiens (human)
cytosolProtein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaHomo sapiens (human)
plasma membraneProtein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaHomo sapiens (human)
CAAX-protein geranylgeranyltransferase complexProtein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaHomo sapiens (human)
microtubule associated complexProtein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaHomo sapiens (human)
protein farnesyltransferase complexProtein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaHomo sapiens (human)
cytoplasmProtein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaHomo sapiens (human)
cytosolProtein farnesyltransferase subunit betaHomo sapiens (human)
microtubule associated complexProtein farnesyltransferase subunit betaHomo sapiens (human)
protein farnesyltransferase complexProtein farnesyltransferase subunit betaHomo sapiens (human)
CAAX-protein geranylgeranyltransferase complexGeranylgeranyl transferase type-1 subunit betaHomo sapiens (human)
cytosolMycothiol S-conjugate amidaseMycobacterium tuberculosis H37Rv
cytosolE3 ubiquitin-protein ligase RNF31Homo sapiens (human)
cytoplasmic side of plasma membraneE3 ubiquitin-protein ligase RNF31Homo sapiens (human)
LUBAC complexE3 ubiquitin-protein ligase RNF31Homo sapiens (human)
CD40 receptor complexE3 ubiquitin-protein ligase RNF31Homo sapiens (human)
nucleusHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
nucleoplasmHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
nuclear speckHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
chromatinHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
nucleusHistone-lysine N-methyltransferase EHMT2Homo sapiens (human)
cytosolRanBP-type and C3HC4-type zinc finger-containing protein 1Homo sapiens (human)
LUBAC complexRanBP-type and C3HC4-type zinc finger-containing protein 1Homo sapiens (human)
cytosolSharpinHomo sapiens (human)
dendriteSharpinHomo sapiens (human)
synapseSharpinHomo sapiens (human)
LUBAC complexSharpinHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (91)

Assay IDTitleYearJournalArticle
AID518911Antimicrobial activity against fluconazole-resistant Cryptococcus gattii serotype B isolate NIH771 at 3.2 ug/ml2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Heteroresistance of Cryptococcus gattii to fluconazole.
AID518896Antimicrobial activity against fluconazole-resistant Cryptococcus gattii serotype B isolate NIH200 at 3.2 ug/ml2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Heteroresistance of Cryptococcus gattii to fluconazole.
AID1315328Inhibition of HIF-1alpha in human PC3 cells assessed as decrease in VEGF mRNA expression level2016Journal of natural products, 05-27, Volume: 79, Issue:5
Screening and Biological Effects of Marine Pyrroloiminoquinone Alkaloids: Potential Inhibitors of the HIF-1α/p300 Interaction.
AID403741Cytotoxicity against human CEM cells after 96 hrs2005Journal of natural products, Aug, Volume: 68, Issue:8
Aspirochlorine class compounds from Aspergillus flavus inhibit azole-resistant Candida albicans.
AID475977Inhibition of Trypanosoma brucei brucei recombinant cathepsin B assessed after 5 mins by spectrofluorimetry2010Bioorganic & medicinal chemistry, Apr-01, Volume: 18, Issue:7
Assessing the trypanocidal potential of natural and semi-synthetic diketopiperazines from two deep water marine-derived fungi.
AID519687Antimicrobial activity against Saccharomyces cerevisiae containing disruption in YKL037W gene by broth microdilution method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Genomewide screening for genes associated with gliotoxin resistance and sensitivity in Saccharomyces cerevisiae.
AID476192Inhibition of NADPH oxidase2010Bioorganic & medicinal chemistry, Apr-01, Volume: 18, Issue:7
Assessing the trypanocidal potential of natural and semi-synthetic diketopiperazines from two deep water marine-derived fungi.
AID1601826Antimycobacterial activity against Mycobacterium tuberculosis incubated for overnight by NCCLS broth dilution method2019European journal of medicinal chemistry, Mar-01, Volume: 165Marine natural products as potential anti-tubercular agents.
AID518907Antimicrobial activity against fluconazole-resistant Cryptococcus gattii serotype B isolate NIH189 at 3.2 ug/ml2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Heteroresistance of Cryptococcus gattii to fluconazole.
AID519674Antimicrobial activity against wild type Saccharomyces cerevisiae BY4741 by broth microdilution method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Genomewide screening for genes associated with gliotoxin resistance and sensitivity in Saccharomyces cerevisiae.
AID93990Inhibition of K-Ras-transformed fibrosarcoma growth1997Journal of medicinal chemistry, Sep-12, Volume: 40, Issue:19
Ras farnesyltransferase: a new therapeutic target.
AID518908Antimicrobial activity against fluconazole-resistant Cryptococcus gattii serotype C isolate NIH34 at 3.2 ug/ml2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Heteroresistance of Cryptococcus gattii to fluconazole.
AID476002Antimicrobial activity against Macrophomina phaseolina2010Bioorganic & medicinal chemistry, Apr-01, Volume: 18, Issue:7
Assessing the trypanocidal potential of natural and semi-synthetic diketopiperazines from two deep water marine-derived fungi.
AID475975Antitrypanosomal activity against Trypanosoma brucei brucei 427-221a after 40 hrs by bioluminescence assay2010Bioorganic & medicinal chemistry, Apr-01, Volume: 18, Issue:7
Assessing the trypanocidal potential of natural and semi-synthetic diketopiperazines from two deep water marine-derived fungi.
AID1371346Inhibition of petit-LUBAC (unknown origin)-mediated ubiquitylation expressed in Escherichia coli BL21 after 2 hrs in presence of E1, UbcH5c, E3 and ubiquitin2018Journal of medicinal chemistry, 04-26, Volume: 61, Issue:8
Interrogating the Roles of Post-Translational Modifications of Non-Histone Proteins.
AID646185Inhibition of HMT-G9a using S-adenosylmethionine and biotinylated H3 peptide after 1 hr2012Journal of natural products, Jan-27, Volume: 75, Issue:1
Gliotoxin analogues from a marine-derived fungus, Penicillium sp., and their cytotoxic and histone methyltransferase inhibitory activities.
AID518905Antimicrobial activity against fluconazole-resistant Cryptococcus gattii serotype B isolate B3939 at 3.2 ug/ml2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Heteroresistance of Cryptococcus gattii to fluconazole.
AID518899Antimicrobial activity against fluconazole-resistant Cryptococcus gattii serotype B isolate NIH535 at 3.2 ug/ml2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Heteroresistance of Cryptococcus gattii to fluconazole.
AID475998Inhibition of chymotrypsin-like activity of 20S proteasome activity2010Bioorganic & medicinal chemistry, Apr-01, Volume: 18, Issue:7
Assessing the trypanocidal potential of natural and semi-synthetic diketopiperazines from two deep water marine-derived fungi.
AID476005Antimicrobial activity against Sclerotium rolfsii2010Bioorganic & medicinal chemistry, Apr-01, Volume: 18, Issue:7
Assessing the trypanocidal potential of natural and semi-synthetic diketopiperazines from two deep water marine-derived fungi.
AID476020Immunomodulatory activity in macrophage assessed as inhibition of phagocytosis2010Bioorganic & medicinal chemistry, Apr-01, Volume: 18, Issue:7
Assessing the trypanocidal potential of natural and semi-synthetic diketopiperazines from two deep water marine-derived fungi.
AID627748Antifungal activity against Candida albicans after 24 hrs by NCCLS M27-P broth macrodilution method2011Journal of natural products, Aug-26, Volume: 74, Issue:8
Isolation, structure, and biological activities of Fellutamides C and D from an undescribed Metulocladosporiella (Chaetothyriales) using the genome-wide Candida albicans fitness test.
AID475987Cytotoxicity against human A549 cells2010Bioorganic & medicinal chemistry, Apr-01, Volume: 18, Issue:7
Assessing the trypanocidal potential of natural and semi-synthetic diketopiperazines from two deep water marine-derived fungi.
AID516310Antimicrobial activity against fluconazole-resistant Cryptococcus gattii serotype B isolate NIH444 at 3.2 ug/ml2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Heteroresistance of Cryptococcus gattii to fluconazole.
AID518898Antimicrobial activity against fluconazole-resistant Cryptococcus gattii serotype B isolate NIH412 at 3.2 ug/ml2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Heteroresistance of Cryptococcus gattii to fluconazole.
AID516315Antimicrobial activity against fluconazole-resistant Cryptococcus gattii serotype B isolate RB3 at 3.2 ug/ml2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Heteroresistance of Cryptococcus gattii to fluconazole.
AID519680Antimicrobial activity against Saccharomyces cerevisiae containing disruption in RAD18 gene by broth microdilution method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Genomewide screening for genes associated with gliotoxin resistance and sensitivity in Saccharomyces cerevisiae.
AID697852Inhibition of electric eel AChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID646184Cytotoxicity against mouse P388 cells after 96 hrs by MTT assay2012Journal of natural products, Jan-27, Volume: 75, Issue:1
Gliotoxin analogues from a marine-derived fungus, Penicillium sp., and their cytotoxic and histone methyltransferase inhibitory activities.
AID475990Cytotoxicity against chinook salmon CHSE-214 cells2010Bioorganic & medicinal chemistry, Apr-01, Volume: 18, Issue:7
Assessing the trypanocidal potential of natural and semi-synthetic diketopiperazines from two deep water marine-derived fungi.
AID700489Inhibition of G9a2012European journal of medicinal chemistry, Oct, Volume: 56Oncoepigenomics: making histone lysine methylation count.
AID476188Ciliostatic activity against human respiratory epithelium assessed as required active concentration2010Bioorganic & medicinal chemistry, Apr-01, Volume: 18, Issue:7
Assessing the trypanocidal potential of natural and semi-synthetic diketopiperazines from two deep water marine-derived fungi.
AID1315332Inhibition of HIF-1alpha in human HCT116 cells assessed as decrease in LDHA mRNA expression level2016Journal of natural products, 05-27, Volume: 79, Issue:5
Screening and Biological Effects of Marine Pyrroloiminoquinone Alkaloids: Potential Inhibitors of the HIF-1α/p300 Interaction.
AID1315330Inhibition of HIF-1alpha in human HCT116 cells assessed as decrease in ENO1 mRNA expression level2016Journal of natural products, 05-27, Volume: 79, Issue:5
Screening and Biological Effects of Marine Pyrroloiminoquinone Alkaloids: Potential Inhibitors of the HIF-1α/p300 Interaction.
AID73585Activity against Farnesyltransferase1997Journal of medicinal chemistry, Sep-12, Volume: 40, Issue:19
Ras farnesyltransferase: a new therapeutic target.
AID475976Inhibition of Trypanosoma brucei brucei recombinant rhodesain after 5 mins by spectrofluorimetry2010Bioorganic & medicinal chemistry, Apr-01, Volume: 18, Issue:7
Assessing the trypanocidal potential of natural and semi-synthetic diketopiperazines from two deep water marine-derived fungi.
AID518912Antimicrobial activity against fluconazole-resistant Cryptococcus gattii serotype C isolate H0058-1-818 at 3.2 ug/ml2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Heteroresistance of Cryptococcus gattii to fluconazole.
AID518902Antimicrobial activity against fluconazole-resistant Cryptococcus gattii serotype B isolate B5788 at 3.2 ug/ml2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Heteroresistance of Cryptococcus gattii to fluconazole.
AID697853Inhibition of horse BChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID476006Antimicrobial activity against Rhizoctonia solani2010Bioorganic & medicinal chemistry, Apr-01, Volume: 18, Issue:7
Assessing the trypanocidal potential of natural and semi-synthetic diketopiperazines from two deep water marine-derived fungi.
AID519682Antimicrobial activity against Saccharomyces cerevisiae containing disruption in YOR345C gene by broth microdilution method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Genomewide screening for genes associated with gliotoxin resistance and sensitivity in Saccharomyces cerevisiae.
AID519676Antimicrobial activity against Saccharomyces cerevisiae containing disruption in IFA38 gene by broth microdilution method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Genomewide screening for genes associated with gliotoxin resistance and sensitivity in Saccharomyces cerevisiae.
AID1597907Acute cytotoxicity against cat CRFK cells assessed as decrease in cell viability at 10 uM measured after 24 hrs by MTT assay relative to control2019Bioorganic & medicinal chemistry, 09-15, Volume: 27, Issue:18
Novel epidithiodiketopiperazines as anti-viral zinc ejectors of the Feline Immunodeficiency Virus (FIV) nucleocapsid protein as a model for HIV infection.
AID700488Inhibition of SUV39H12012European journal of medicinal chemistry, Oct, Volume: 56Oncoepigenomics: making histone lysine methylation count.
AID518906Antimicrobial activity against fluconazole-resistant Cryptococcus gattii serotype B isolate NIH184 at 3.2 ug/ml2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Heteroresistance of Cryptococcus gattii to fluconazole.
AID475988Cytotoxicity against rainbow trout RTS11 cells2010Bioorganic & medicinal chemistry, Apr-01, Volume: 18, Issue:7
Assessing the trypanocidal potential of natural and semi-synthetic diketopiperazines from two deep water marine-derived fungi.
AID518901Antimicrobial activity against fluconazole-resistant Cryptococcus gattii serotype B isolate B4506 at 3.2 ug/ml2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Heteroresistance of Cryptococcus gattii to fluconazole.
AID623315Cytotoxicity against human DU145 cells at 2.5 to 80 uM after 24 hrs by cell counting kit analysis2011Journal of natural products, Oct-28, Volume: 74, Issue:10
Glionitrin B, a cancer invasion inhibitory diketopiperazine produced by microbial coculture.
AID519675Antimicrobial activity against Saccharomyces cerevisiae containing disruption in SNF1 gene by broth microdilution method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Genomewide screening for genes associated with gliotoxin resistance and sensitivity in Saccharomyces cerevisiae.
AID475994Inhibition of PAF2010Bioorganic & medicinal chemistry, Apr-01, Volume: 18, Issue:7
Assessing the trypanocidal potential of natural and semi-synthetic diketopiperazines from two deep water marine-derived fungi.
AID476189Induction of apoptosis in human HSC assessed as required active concentration2010Bioorganic & medicinal chemistry, Apr-01, Volume: 18, Issue:7
Assessing the trypanocidal potential of natural and semi-synthetic diketopiperazines from two deep water marine-derived fungi.
AID739835Induction of apoptosis in human neutrophils assessed as pre-necrotic cells at 3 uM after 6 hrs by annexin V/propidium iodide staining based flow cytometric analysis in presence of PTIO2013Bioorganic & medicinal chemistry, Apr-01, Volume: 21, Issue:7
Novel R-roscovitine NO-donor hybrid compounds as potential pro-resolution of inflammation agents.
AID403740Antifungal activity against azole-resistant Candida albicans 99-7882005Journal of natural products, Aug, Volume: 68, Issue:8
Aspirochlorine class compounds from Aspergillus flavus inhibit azole-resistant Candida albicans.
AID519677Antimicrobial activity against Saccharomyces cerevisiae containing disruption in OP11 gene by broth microdilution method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Genomewide screening for genes associated with gliotoxin resistance and sensitivity in Saccharomyces cerevisiae.
AID476001Antimicrobial activity against Rhizoctonia bataticola2010Bioorganic & medicinal chemistry, Apr-01, Volume: 18, Issue:7
Assessing the trypanocidal potential of natural and semi-synthetic diketopiperazines from two deep water marine-derived fungi.
AID519683Antimicrobial activity against Saccharomyces cerevisiae containing disruption in YLR456W gene by broth microdilution method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Genomewide screening for genes associated with gliotoxin resistance and sensitivity in Saccharomyces cerevisiae.
AID518910Antimicrobial activity against fluconazole-resistant Cryptococcus gattii serotype B isolate NIH409 at 3.2 ug/ml2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Heteroresistance of Cryptococcus gattii to fluconazole.
AID518897Antimicrobial activity against fluconazole-resistant Cryptococcus gattii serotype B isolate NIH754 at 3.2 ug/ml2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Heteroresistance of Cryptococcus gattii to fluconazole.
AID74786Inhibition of [3H]-GGPP incorporation into recombinant human Ha-Ras-CVLL by Geranylgeranyl transferase type I2003Bioorganic & medicinal chemistry letters, Nov-03, Volume: 13, Issue:21
Pyrazino[1,2-a]indole-1,4-diones, simple analogues of gliotoxin, as selective inhibitors of geranylgeranyltransferase I.
AID518900Antimicrobial activity against fluconazole-resistant Cryptococcus gattii serotype C isolate NIH257 at 3.2 ug/ml2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Heteroresistance of Cryptococcus gattii to fluconazole.
AID623317Antiinvasive activity against human DU145 cells at 0.2 uM after 24 hrs by cell invasion assay2011Journal of natural products, Oct-28, Volume: 74, Issue:10
Glionitrin B, a cancer invasion inhibitory diketopiperazine produced by microbial coculture.
AID518903Antimicrobial activity against fluconazole-resistant Cryptococcus gattii serotype B isolate B5763 at 3.2 ug/ml2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Heteroresistance of Cryptococcus gattii to fluconazole.
AID475989Cytotoxicity against rainbow trout RTG2 cells2010Bioorganic & medicinal chemistry, Apr-01, Volume: 18, Issue:7
Assessing the trypanocidal potential of natural and semi-synthetic diketopiperazines from two deep water marine-derived fungi.
AID519685Antimicrobial activity against Saccharomyces cerevisiae containing disruption in CYS3 gene by broth microdilution method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Genomewide screening for genes associated with gliotoxin resistance and sensitivity in Saccharomyces cerevisiae.
AID475996Activation of NF-kappaB in human jurkat cells assessed as active concentration required2010Bioorganic & medicinal chemistry, Apr-01, Volume: 18, Issue:7
Assessing the trypanocidal potential of natural and semi-synthetic diketopiperazines from two deep water marine-derived fungi.
AID646186Inhibition of HMT-set7/9 using S-adenosylmethionine and biotinylated H3 peptide at 100 uM after 1 hr2012Journal of natural products, Jan-27, Volume: 75, Issue:1
Gliotoxin analogues from a marine-derived fungus, Penicillium sp., and their cytotoxic and histone methyltransferase inhibitory activities.
AID1315327Inhibition of HIF-1alpha in human PC3 cells assessed as decrease in ENO1 mRNA expression level2016Journal of natural products, 05-27, Volume: 79, Issue:5
Screening and Biological Effects of Marine Pyrroloiminoquinone Alkaloids: Potential Inhibitors of the HIF-1α/p300 Interaction.
AID475985Cytotoxicity against human HeLa cells2010Bioorganic & medicinal chemistry, Apr-01, Volume: 18, Issue:7
Assessing the trypanocidal potential of natural and semi-synthetic diketopiperazines from two deep water marine-derived fungi.
AID476009Antiparasitic activity against chloroquine-resistant Plasmodium falciparum K12010Bioorganic & medicinal chemistry, Apr-01, Volume: 18, Issue:7
Assessing the trypanocidal potential of natural and semi-synthetic diketopiperazines from two deep water marine-derived fungi.
AID519686Antimicrobial activity against Saccharomyces cerevisiae containing disruption in MEF2 gene by broth microdilution method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Genomewide screening for genes associated with gliotoxin resistance and sensitivity in Saccharomyces cerevisiae.
AID73280Inhibition of [3H]FPP incorporation into recombinant human Ha-Ras-CVLS by farnesyl transferase2003Bioorganic & medicinal chemistry letters, Nov-03, Volume: 13, Issue:21
Pyrazino[1,2-a]indole-1,4-diones, simple analogues of gliotoxin, as selective inhibitors of geranylgeranyltransferase I.
AID1881910Inhibition of PKM2 (unknown origin) Hie78, Arg73, Thr328 residues by coloroimetric/fluorometric assay2022Journal of medicinal chemistry, 01-27, Volume: 65, Issue:2
A Perspective on Medicinal Chemistry Approaches for Targeting Pyruvate Kinase M2.
AID475991Antiprotozoal activity against Tetrahymena pyriformis2010Bioorganic & medicinal chemistry, Apr-01, Volume: 18, Issue:7
Assessing the trypanocidal potential of natural and semi-synthetic diketopiperazines from two deep water marine-derived fungi.
AID476004Antimicrobial activity against Pythium aphanidermatum2010Bioorganic & medicinal chemistry, Apr-01, Volume: 18, Issue:7
Assessing the trypanocidal potential of natural and semi-synthetic diketopiperazines from two deep water marine-derived fungi.
AID519678Antimicrobial activity against Saccharomyces cerevisiae containing disruption in RTG2 gene by broth microdilution method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Genomewide screening for genes associated with gliotoxin resistance and sensitivity in Saccharomyces cerevisiae.
AID518904Antimicrobial activity against fluconazole-resistant Cryptococcus gattii serotype B isolate NIH198 at 3.2 ug/ml2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Heteroresistance of Cryptococcus gattii to fluconazole.
AID475997Inhibition of Saccharomyces cerevisiae acetolactate synthase2010Bioorganic & medicinal chemistry, Apr-01, Volume: 18, Issue:7
Assessing the trypanocidal potential of natural and semi-synthetic diketopiperazines from two deep water marine-derived fungi.
AID476003Antimicrobial activity against Pythium debaryanum2010Bioorganic & medicinal chemistry, Apr-01, Volume: 18, Issue:7
Assessing the trypanocidal potential of natural and semi-synthetic diketopiperazines from two deep water marine-derived fungi.
AID475995Inhibition of Mycobacterium tuberculosis mycothiol-S-conjugate amidase2010Bioorganic & medicinal chemistry, Apr-01, Volume: 18, Issue:7
Assessing the trypanocidal potential of natural and semi-synthetic diketopiperazines from two deep water marine-derived fungi.
AID1315331Inhibition of HIF-1alpha in human HCT116 cells assessed as decrease in VEGF mRNA expression level2016Journal of natural products, 05-27, Volume: 79, Issue:5
Screening and Biological Effects of Marine Pyrroloiminoquinone Alkaloids: Potential Inhibitors of the HIF-1α/p300 Interaction.
AID519679Antimicrobial activity against Saccharomyces cerevisiae containing disruption in APL2 gene by broth microdilution method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Genomewide screening for genes associated with gliotoxin resistance and sensitivity in Saccharomyces cerevisiae.
AID475978Cytotoxicity against human Jurkat cells after 40 hrs bioluminescence assay2010Bioorganic & medicinal chemistry, Apr-01, Volume: 18, Issue:7
Assessing the trypanocidal potential of natural and semi-synthetic diketopiperazines from two deep water marine-derived fungi.
AID519681Antimicrobial activity against Saccharomyces cerevisiae containing disruption in YGL235W gene by broth microdilution method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Genomewide screening for genes associated with gliotoxin resistance and sensitivity in Saccharomyces cerevisiae.
AID476017Toxicity in ip dosed ddY mouse2010Bioorganic & medicinal chemistry, Apr-01, Volume: 18, Issue:7
Assessing the trypanocidal potential of natural and semi-synthetic diketopiperazines from two deep water marine-derived fungi.
AID623314Cytotoxicity against human DU145 cells at 0.25 to 8 uM after 24 hrs by cell counting kit analysis2011Journal of natural products, Oct-28, Volume: 74, Issue:10
Glionitrin B, a cancer invasion inhibitory diketopiperazine produced by microbial coculture.
AID1272152Neuroprotective against IFNgamma/LPS stimulated THP1 condition medium-induced neurotoxicity in human SH-SY5Y cells assessed as increase in cytoplasmic IkappaBalpha level pretreated for 1 hr followed by addition of THP1 conditioned medium by western blot a2016European journal of medicinal chemistry, Jan-27, Volume: 108Development of glycine-α-methyl-proline-containing tripeptides with neuroprotective properties.
AID475986Cytotoxicity against HUVEC2010Bioorganic & medicinal chemistry, Apr-01, Volume: 18, Issue:7
Assessing the trypanocidal potential of natural and semi-synthetic diketopiperazines from two deep water marine-derived fungi.
AID518913Antimicrobial activity against fluconazole-resistant Cryptococcus gattii serotype C isolate H00581-1941 at 3.2 ug/ml2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Heteroresistance of Cryptococcus gattii to fluconazole.
AID519684Antimicrobial activity against Saccharomyces cerevisiae containing disruption in YGL072C gene by broth microdilution method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Genomewide screening for genes associated with gliotoxin resistance and sensitivity in Saccharomyces cerevisiae.
AID1315329Inhibition of HIF-1alpha in human PC3 cells assessed as decrease in LDHA mRNA expression level2016Journal of natural products, 05-27, Volume: 79, Issue:5
Screening and Biological Effects of Marine Pyrroloiminoquinone Alkaloids: Potential Inhibitors of the HIF-1α/p300 Interaction.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (455)

TimeframeStudies, This Drug (%)All Drugs %
pre-199065 (14.29)18.7374
1990's61 (13.41)18.2507
2000's148 (32.53)29.6817
2010's145 (31.87)24.3611
2020's36 (7.91)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 46.33

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index46.33 (24.57)
Research Supply Index6.15 (2.92)
Research Growth Index4.72 (4.65)
Search Engine Demand Index73.77 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (46.33)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.21%)5.53%
Reviews30 (6.41%)6.00%
Case Studies3 (0.64%)4.05%
Observational0 (0.00%)0.25%
Other434 (92.74%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]